Skip to main navigation Skip to search Skip to main content

Randomized, Double-Blind, Phase 3 Trial to Compare the efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Patients with Metastatic Chemotherapy-Naive Castration Resistant Prostate Cancer

Project: Research

Project Details

StatusFinished
Effective start/end date08/19/10 → 07/7/12

Funding

  • Bristol Myers Squibb Company: $5,500.00